Drägerwerk AG & Co. KGaA Reports Record 2025 Performance, Dividend Increase, and Defense Sector Growth
Drägerwerk AG & Co. KGaA reported record net sales in 2025 with 5% currency-adjusted growth, a 6.7% EBIT margin, and €140m in free cash flow. The company plans to increase its dividend by 10% and is focusing on profitability and growth in defense and medical interoperability. The 2026 outlook includes 2–6% currency-adjusted sales growth and an EBIT margin of 5–7.5%.
Topics: defense_growth dividend_hike financial_performance market_outlook profitability